These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36341738)

  • 1. Potassium-Competitive Acid Blocker Suppression of Gastric Acid in Erosive Esophagitis: Is Stronger and Longer Better?
    Katzka DA; Kahrilas PJ
    Gastroenterology; 2023 Jan; 164(1):14-15. PubMed ID: 36341738
    [No Abstract]   [Full Text] [Related]  

  • 2. The Effects of Switching to Vonoprazan, a Novel Potassium-Competitive Acid Blocker, on Gastric Acidity and Reflux Patterns in Patients with Erosive Esophagitis Refractory to Proton Pump Inhibitors.
    Yamashita H; Kanamori A; Kano C; Hashimura H; Matsumoto K; Tsujimae M; Yoshizaki T; Momose K; Obata D; Eguchi T; Fujita M; Okada A
    Digestion; 2017; 96(1):52-59. PubMed ID: 28662503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux.
    Akiyama J; Hosaka H; Kuribayashi S; Moriyasu S; Hisada Y; Okubo H; Watanabe K; Imbe K; Nagata N; Kojima Y; Yokoi C; Uemura N; Shimoyama Y; Kawamura O; Yamada M; Kusano M
    Digestion; 2020; 101(2):174-183. PubMed ID: 30897577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of GERD: Are Potassium-Competitive Acid Blockers Superior to Proton Pump Inhibitors?
    Kinoshita Y; Ishimura N; Ishihara S
    Am J Gastroenterol; 2018 Oct; 113(10):1417-1419. PubMed ID: 29955116
    [No Abstract]   [Full Text] [Related]  

  • 5. [Potassium-competitive acid blocker].
    Haruma K; Suehiro M; Kawamoto H; Manabe N
    Nihon Rinsho; 2016 Aug; 74(8):1311-1315. PubMed ID: 30562434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study.
    Tolia V; Youssef NN; Gilger MA; Traxler B; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S24-30. PubMed ID: 26422095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When proton pump inhibitors fail.
    Kahrilas PJ
    Clin Gastroenterol Hepatol; 2008 May; 6(5):482-3. PubMed ID: 18378500
    [No Abstract]   [Full Text] [Related]  

  • 8. Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study.
    Tolia V; Youssef NN; Gilger MA; Traxler B; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S24-30. PubMed ID: 26121347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study.
    Tolia V; Youssef NN; Gilger MA; Traxler B; Illueca M
    BMC Pediatr; 2010 Jun; 10():41. PubMed ID: 20540767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The treatment for reflux esophagitis which is refractory to proton pump inhibitor therapy].
    Adachi K
    Nihon Shokakibyo Gakkai Zasshi; 2006 Nov; 103(11):1233-7. PubMed ID: 17085903
    [No Abstract]   [Full Text] [Related]  

  • 11. Sustained Acid Suppression by Potassium-Competitive Acid Blocker (P-CAB) May Be An Attractive Treatment Candidate for Patients with Eosinophilic Esophagitis.
    Ishimura N; Ishihara S; Kinoshita Y
    Am J Gastroenterol; 2016 Aug; 111(8):1203-4. PubMed ID: 27481423
    [No Abstract]   [Full Text] [Related]  

  • 12. Dexlansoprazole (Kapidex) for GERD and erosive esophagitis.
    Med Lett Drugs Ther; 2009 Mar; 51(1308):21-2. PubMed ID: 19305367
    [No Abstract]   [Full Text] [Related]  

  • 13. Proton pump inhibitors: the good, the bad, and the unwanted.
    Chubineh S; Birk J
    South Med J; 2012 Nov; 105(11):613-8. PubMed ID: 23128806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor effectiveness of PPIs in non-erosive reflux disease: the truth in the end!
    Scarpignato C
    Neurogastroenterol Motil; 2013 Aug; 25(8):707. PubMed ID: 23711158
    [No Abstract]   [Full Text] [Related]  

  • 15. Esophagitis in Pediatric Esophageal Atresia: Acid May Not Always Be the Issue.
    Yasuda JL; Clark SJ; Staffa SJ; Blansky B; Ngo PD; Hamilton TE; Smithers CJ; Jennings R; Manfredi MA
    J Pediatr Gastroenterol Nutr; 2019 Aug; 69(2):163-170. PubMed ID: 30921254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erosive oesophagitis with particular reference to Asians.
    Goh KL; Mahadeva S; Ho SH
    Aliment Pharmacol Ther; 2011 Oct; 34(7):821-2; author reply 823. PubMed ID: 21896044
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term outcomes of patients with symptomatic gastroesophageal reflux disease treated with vonoprazan.
    Shinozaki S; Osawa H; Kobayashi Y; Sakamoto H; Hayashi Y; Miura Y; Kawarai Lefor A; Yamamoto H
    Scand J Gastroenterol; 2018 Aug; 53(8):897-904. PubMed ID: 30056768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vonoprazan versus proton-pump inhibitors for healing gastroesophageal reflux disease: A systematic review.
    Miyazaki H; Igarashi A; Takeuchi T; Teng L; Uda A; Deguchi H; Higuchi K; Tango T
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1316-1328. PubMed ID: 30883868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the clinical and economic impact of using esomeprazole or lansoprazole for the treatment of erosive esophagitis.
    Raghunath AS; Green JR; Edwards SJ
    Clin Ther; 2003 Jul; 25(7):2088-101. PubMed ID: 12946553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium-competitive acid blockers and gastroesophageal reflux disease.
    Leowattana W; Leowattana T
    World J Gastroenterol; 2022 Jul; 28(28):3608-3619. PubMed ID: 36161043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.